| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Corvus Pharmaceuticals, Inc. (CRVS) has 8 insiders with recent SEC Form 4 filings, including 12 buys and 5 sells. CRVS is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 8.34M | $99.35M | - | |
| CEO | 1.00M | $11.91M | - | |
| Other | 400.0K | $4.76M | - | |
| CFO | 400.0K | $4.76M | - | |
| Other | 100.0K | $1.19M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 17, 2021 | Thompson Peter A.65 | Director, 10% Owner | Buy | 1,285,714 | $3.50 | $4,499,999.00 | +19.0% | |
| Feb 17, 2021 | Orbimed Advisors LLC67 | Director, 10% Owner | Buy | 1,285,714 | $3.50 | $4,499,999.00 | +19.0% | |
| Feb 17, 2021 | Miller Richard A Md64 | President And CEO | Buy | 100,000 | $3.50 | $350,000.00 | +8.5% | |
| Jul 8, 2020 | Novo Holdings A/s58 | 10% Owner | Sell | 1,538,062 | $5.31 | $8,168,546.63 | -30.4% | |
| Nov 13, 2019 | Miller Richard A Md64 | President And CEO | Buy | 15,008 | $3.00 | $45,029.22 | +0.6% | |
| Aug 7, 2019 | Miller Richard A Md64 | President And CEO | Buy | 7,500 | $3.56 | $26,725.00 | +0.3% | |
| Aug 6, 2019 | Orbimed Advisors LLC67 | Director, 10% Owner | Buy | 142,656 | $3.51 | $500,722.56 | +2.2% | |
| Aug 6, 2019 | Thompson Peter A.65 | Director, 10% Owner | Buy | 142,656 | $3.51 | $500,722.56 | +2.2% | |
| Jul 25, 2019 | Novo Holdings A/s58 | 10% Owner | Sell | 1,492,956 | $4.07 | $6,077,845.33 | -11.4% | |
| Jul 1, 2019 | Thompson Peter A.65 | Director, 10% Owner | Buy | 657,344 | $3.72 | $2,444,065.11 | +3.5% |